Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hoth Therapeutics

0.8990
+0.04805.64%
Pre-market: 0.8802-0.0188-2.09%06:59 EDT
Volume:121.11K
Turnover:105.01K
Market Cap:11.84M
PE:-0.70
High:0.9100
Open:0.8500
Low:0.8267
Close:0.8510
Loading ...
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2022

Major Issues Report

8-K - Current report
Oct 24, 2022

Major Issues Report

8-K - Current report
Aug 22, 2022

Major Issues Report

8-K - Current report
Aug 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 18, 2022

Major Issues Report

8-K - Current report
Jul 01, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jul 01, 2022

Major Issues Report

8-K - Current report
Jun 23, 2022

Major Issues Report

8-K - Current report
Jun 13, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2022

Major Issues Report

8-K - Current report
Apr 13, 2022

Major Issues Report

8-K - Current report
Apr 05, 2022

Major Issues Report

8-K - Current report
Mar 30, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 03, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals